UBS Group
ARDT

UBS Group’s Ardent Health ARDT Stock Holding History

UBS Group’s Portfolio ARDT Stock Details ARDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.36M Sell
442,619
-8,061
-2% -$76.4K ﹤0.01% 4324
2026
Q1 		$3.86M Buy
450,680
+334,003
+286% +$3M ﹤0.01% 4337
2025
Q4 		$1.03M Sell
116,677
-11,150
-9% -$129K ﹤0.01% 5548
2025
Q3 		$1.69M Buy
127,827
+119,271
+1,394% +$1.49M ﹤0.01% 5117
2025
Q2 		$117K Sell
8,556
-5,443
-39% -$73.3K ﹤0.01% 7102
2025
Q1 		$192K Sell
13,999
-38,334
-73% -$559K ﹤0.01% 6589
2024
Q4 		$894K Buy
52,333
+44,613
+578% +$773K ﹤0.01% 5390
2024
Q3 		$142K Buy
+7,720
New +$136K ﹤0.01% 6107

Other funds holding ARDT

CTC
Chai Trust Company Chicago, Illinois $1.45B AUM 10.17% 1-Year Est. Return
VI
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
CM
CastleKnight Management New York $7.38B AUM 133.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group's ARDT Position: Q2 2026 in Review

UBS Group reduced its Ardent Health (ARDT) stake by 1.8% in Q2 2026, selling an estimated $76.4K and leaving 442,619 shares worth $4.36M. The position accounts for ﹤0.01% of the portfolio, ranked #4324.

UBS Group first reported a position in ARDT in Q3 2024 and has held it in 8 quarters since. 139 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

  • UBS Group held 442,619 shares of Ardent Health worth $4.36M as of Q2 2026.
  • UBS Group sold 8,061 Ardent Health shares in Q2 2026, an estimated $76.4K.
  • Ardent Health made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #4324 holding.
  • UBS Group first reported a position in Ardent Health in Q3 2024 and has held it in 8 quarters since.
  • 139 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.